This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
  • 00
  • 00
  • 00
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Montserrat Vendrell
Partner at Aliath Bioventures


Montserrat Vendrell (Barcelona, 1964) is partner at Aliath Bioventures since 2023 and at Alta Life Sciences since 2016. She is Board Director at Peptomyc, Ona Therapeutics, Inbrain Neuroelectronics and Accure therapeutics. Dr. Vendrell has over 10-year experience in biomedical research both in Spanish institutions (CSIC, 1987-1991; 1995-1997) and international companies (Roche Institute of Molecular Biology, 1992-1994), and +20 years in supporting entrepreneurs in life sciences.

Dr.Vendrell was founder and CEO of Biocat, Catalonia biocluster, one of the most successful in Europe (2007-2015). She also chaired the Council of European Bioregions since its birth till 2015. Previously, Montserrat was part of the founding team of Barcelona Science Park, where she was responsible for the design and management of the park, its bioincubator, and technological platforms (Deputy CEO and later, CEO; 1997-2007; 2014-2015).

Dr. Vendrell holds a PhD in Biology from University of Barcelona (1991), a master’s degree in science communication from Pompeu Fabra University (Barcelona, 1997) and an Executive Degree in General Management (PDG IESE Business School, Barcelona, 2007).

Vendrell currently chairs the Executive Committee of the Pasqual Maragall Foundation (Alzheimer’s disease) and the Board of Trustees of UPF (Pompeu Fabra University).

Agenda Sessions

  • Startup stories: how it started, how it’s going